SHOULDER INNOVATIONS, INC. (SI) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

SHOULDER INNOVATIONS, INC. (SI) Healthcare & Pipeline Overview

Shoulder Innovations, Inc. is a medical device manufacturer specializing in shoulder replacement systems. With a focus on innovation and patient outcomes, the company operates within the competitive medical specialties sector, holding a significant gross margin of 76.5% despite current negative profitability. The company was founded in 2009.

What Is the Investment Thesis for SI?

Shoulder Innovations, Inc. presents a compelling, albeit high-risk, investment thesis centered on its innovative shoulder replacement system and potential for market penetration. The company's high gross margin of 76.5% indicates strong pricing power and efficient manufacturing. However, the negative profit margin of -85.3% highlights significant operational challenges that need to be addressed. Key growth catalysts include expanding sales and marketing efforts to increase market share and securing additional regulatory approvals for new product iterations. Successful execution of these strategies could drive revenue growth and improve profitability. The company's beta of -2.12 suggests a low correlation with the broader market, potentially offering diversification benefits. However, investors should carefully consider the risks associated with the company's financial performance and competitive landscape. The company's success hinges on its ability to scale operations, manage costs effectively, and maintain its technological edge in the shoulder replacement market.

Based on FMP financials and quantitative analysis

SI Key Highlights

Market capitalization of $417M indicates the company's current valuation in the market.

• Gross margin of 76.5% reflects strong pricing power and efficient manufacturing processes.
• Negative profit margin of -85.3% highlights significant operational and cost management challenges.
• Beta of -2.12 suggests a low correlation with the broader market, potentially offering diversification benefits.
• The company was founded in 2009, indicating over a decade of experience in the medical device industry.

Who Are SI's Competitors?

SI is benchmarked below against 4 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are SI's Key Strengths?

Innovative shoulder replacement system.

• High gross margin.
• Experienced management team.
• Focus on patient outcomes.

What Are SI's Weaknesses?

Negative profit margin.

• Limited product line.
• High reliance on a single product.
• Relatively small market capitalization.

What Could Drive SI Stock Higher?

Potential FDA approval for new shoulder replacement system enhancements by Q4 2026.

• Expansion of sales and marketing efforts into new geographic regions throughout 2026.
• Strategic partnerships with key orthopedic clinics to increase market penetration.

What Are the Key Risks for SI?

Negative return on equity (-25.7%) — the business is not currently generating profit on shareholder capital.

• Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
• Insider selling — insiders were net sellers of roughly $5.3M recently.
• Increased competition from larger orthopedic device companies eroding market share.
• Regulatory hurdles and delays in obtaining FDA approvals for new products.
• Economic downturn affecting healthcare spending and demand for elective surgeries.
• Product liability claims and associated legal costs.

What Are the Growth Opportunities for SI?

• Growth opportunity 1: Expanding the product line to include a wider range of shoulder replacement options, such as reverse shoulder replacements and partial replacements, can address a broader patient demographic. The market for shoulder replacement is expected to grow, driven by an aging population and increasing prevalence of shoulder arthritis. Successfully introducing new products could increase revenue by 20% within the next three years.
• Growth opportunity 2: Securing additional regulatory approvals, such as FDA clearance for new product iterations or expanded indications, can enhance the company's market position and credibility. The regulatory approval process can be lengthy and costly, but successful approvals can lead to increased sales and market access. Achieving these approvals within the next two years could significantly boost investor confidence and drive stock appreciation.
• Growth opportunity 3: Expanding the sales and marketing efforts to target new geographic markets, both domestically and internationally, can drive revenue growth. Focusing on regions with a high prevalence of shoulder injuries and arthritis can be particularly effective. International expansion could increase revenue by 15% within the next five years, but requires careful consideration of regulatory and cultural differences.
• Growth opportunity 4: Developing strategic partnerships with hospitals and orthopedic clinics can provide access to a wider patient base and streamline the sales process. Collaborating with key opinion leaders and influential surgeons can also enhance the company's reputation and credibility. Establishing these partnerships within the next year could lead to a more efficient sales cycle and increased market penetration.
• Growth opportunity 5: Investing in research and development to create next-generation shoulder replacement systems with enhanced features, such as improved biocompatibility and longer lifespan, can maintain the company's competitive edge. Continuous innovation is crucial in the medical device industry to stay ahead of competitors and meet evolving patient needs. A successful R&D program could lead to the introduction of groundbreaking products within the next five years, further solidifying the company's market leadership.

What Are SI's Competitive Advantages?

• Proprietary shoulder replacement system design.
• Focus on innovation and patient outcomes.
• Established relationships with orthopedic surgeons and clinics.

What Does SI Do?

Shoulder Innovations, Inc., founded in 2009 by Stephen B. Gunther and Michael DeVries, is a medical device company focused on the design, development, and manufacturing of innovative orthopedic solutions. Headquartered in Grand Rapids, MI, the company's primary product is a shoulder replacement system aimed at improving patient outcomes and surgical procedures. Shoulder Innovations operates within the medical specialties sector, targeting the specific needs of orthopedic surgeons and patients requiring shoulder joint replacement. The company's focus is on creating advanced medical devices that offer improved functionality, durability, and ease of use compared to traditional shoulder replacement systems. By concentrating on this niche market, Shoulder Innovations aims to establish itself as a leader in shoulder arthroplasty. Their product is designed to address the limitations of existing solutions, potentially reducing complications and enhancing the overall patient experience. The company distributes its products through a network of sales representatives and distributors, targeting hospitals and orthopedic clinics across the United States. Shoulder Innovations continues to invest in research and development to expand its product line and improve its existing offerings. The company's long-term strategy involves expanding its market share within the shoulder replacement market and potentially diversifying into other orthopedic specialties. With a team of approximately 300 employees, Shoulder Innovations is structured to support its manufacturing, sales, and research activities. The company's commitment to innovation and patient care positions it as a notable player in the medical device industry.

What Products and Services Does SI Offer?

• Designs and manufactures shoulder replacement systems.
• Focuses on innovative orthopedic solutions.
• Targets patients requiring shoulder joint replacement.
• Offers advanced medical devices for improved functionality.
• Distributes products through sales representatives and distributors.
• Invests in research and development for product improvement.

How Does SI Make Money?

• Develops and manufactures shoulder replacement systems.
• Sells products to hospitals and orthopedic clinics.
• Generates revenue through direct sales and distribution agreements.

What Industry Does SI Operate In?

Shoulder Innovations, Inc. operates within the medical specialties sector, specifically focusing on orthopedic devices. The global orthopedic device market is projected to reach $60 billion by 2026, driven by an aging population and increasing demand for joint replacement surgeries. The competitive landscape includes established players like Zimmer Biomet and Stryker, as well as smaller, specialized companies. Shoulder Innovations aims to differentiate itself through innovative product design and a focus on patient outcomes. The company's success depends on its ability to capture market share in this growing but competitive environment.

Who Are SI's Key Customers?

• Orthopedic clinics
• Orthopedic surgeons

Company Profile

SHOULDER INNOVATIONS, INC. operates in the Medical - Specialties industry within the Healthcare sector. It is headquartered in Grand Rapids, US. The company is led by CEO Robert Joseph Ball. SI has traded publicly since 2025.

SHOULDER INNOVATIONS, INC. Financial Trajectory

SHOULDER INNOVATIONS, INC. (SI) reported $17.2M in revenue for Q2 FY2026, reflecting 2.8% growth compared to the prior quarter. The company recorded a net loss of $10.2M, with diluted EPS of $-0.49. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this small-cap Healthcare company. Across the four most recent quarters, SI averaged $-0.42 in diluted EPS.

How SHOULDER INNOVATIONS, INC. Is Valued

SHOULDER INNOVATIONS, INC. carries a market capitalization of $417M, placing it in the small-cap category. Analyst price targets span from $19.00 to $28.00, with a consensus of $23.50. At the current price of $20.11, that implies approximately 17% upside potential. Relative to its peer group, SI's quantitative score of 36/100 is below the peer average of 78/100.

Return on equity for SHOULDER INNOVATIONS, INC. stands at -25.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -23.0%, showing how much profit it generates from its asset base. Its free cash flow yield is -11.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 10.71 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -8.6%, the inverse of the P/E and a quick read on earnings relative to price.

SHOULDER INNOVATIONS, INC.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 8.71 places it in the safe zone, indicating low near-term bankruptcy risk.

SHOULDER INNOVATIONS, INC. has missed Wall Street's EPS estimate in 2 of its last 5 reported quarters — a mixed record worth weighing. Reported results have landed about 2029.1% below estimates on average.

Over the past six months, SHOULDER INNOVATIONS, INC. insiders filed 28 SEC Form 4 transactions — 20 sales and 8 purchases. On net that is roughly 214K shares disposed (about $5.3M), a signal worth weighing alongside the fundamentals.

SI Financials

SI Latest News

SI Analyst Consensus

SI MoonshotScore

Common Questions About SI (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources